BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

510 related articles for article (PubMed ID: 32175074)

  • 1. mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges.
    Zou Z; Tao T; Li H; Zhu X
    Cell Biosci; 2020; 10():31. PubMed ID: 32175074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of Autophagy Increases Proliferation Inhibition and Apoptosis Induced by the PI3K/mTOR Inhibitor NVP-BEZ235 in Breast Cancer Cells.
    Ji Y; Di W; Yang Q; Lu Z; Cai W; Wu J
    Clin Lab; 2015; 61(8):1043-51. PubMed ID: 26427150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. mTOR is a fine tuning molecule in CDK inhibitors-induced distinct cell death mechanisms via PI3K/AKT/mTOR signaling axis in prostate cancer cells.
    Berrak O; Arisan ED; Obakan-Yerlikaya P; Coker-Gürkan A; Palavan-Unsal N
    Apoptosis; 2016 Oct; 21(10):1158-78. PubMed ID: 27484210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mammalian target of rapamycin: discovery of rapamycin reveals a signaling pathway important for normal and cancer cell growth.
    Gibbons JJ; Abraham RT; Yu K
    Semin Oncol; 2009 Dec; 36 Suppl 3():S3-S17. PubMed ID: 19963098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apoptosis and antitumor effects induced by the combination of an mTOR inhibitor and an autophagy inhibitor in human osteosarcoma MG63 cells.
    Horie R; Nakamura O; Yamagami Y; Mori M; Nishimura H; Fukuoka N; Yamamoto T
    Int J Oncol; 2016 Jan; 48(1):37-44. PubMed ID: 26530936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mammalian target of rapamycin (mTOR) as a potential therapeutic target in various diseases.
    Kaur A; Sharma S
    Inflammopharmacology; 2017 Jun; 25(3):293-312. PubMed ID: 28417246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. mTOR Signaling in Cancer and mTOR Inhibitors in Solid Tumor Targeting Therapy.
    Tian T; Li X; Zhang J
    Int J Mol Sci; 2019 Feb; 20(3):. PubMed ID: 30754640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pro-apoptotic and pro-autophagic effects of the Aurora kinase A inhibitor alisertib (MLN8237) on human osteosarcoma U-2 OS and MG-63 cells through the activation of mitochondria-mediated pathway and inhibition of p38 MAPK/PI3K/Akt/mTOR signaling pathway.
    Niu NK; Wang ZL; Pan ST; Ding HQ; Au GH; He ZX; Zhou ZW; Xiao G; Yang YX; Zhang X; Yang T; Chen XW; Qiu JX; Zhou SF
    Drug Des Devel Ther; 2015; 9():1555-84. PubMed ID: 25792811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salidroside attenuates hypoxia-induced pulmonary arterial smooth muscle cell proliferation and apoptosis resistance by upregulating autophagy through the AMPK-mTOR-ULK1 pathway.
    Gui D; Cui Z; Zhang L; Yu C; Yao D; Xu M; Chen M; Wu P; Li G; Wang L; Huang X
    BMC Pulm Med; 2017 Dec; 17(1):191. PubMed ID: 29233105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting mTOR as a Cancer Therapy: Recent Advances in Natural Bioactive Compounds and Immunotherapy.
    Bouyahya A; El Allam A; Aboulaghras S; Bakrim S; El Menyiy N; Alshahrani MM; Al Awadh AA; Benali T; Lee LH; El Omari N; Goh KW; Ming LC; Mubarak MS
    Cancers (Basel); 2022 Nov; 14(22):. PubMed ID: 36428613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of two novel inhibitors of mTOR signaling pathway based on high content screening.
    Yan J; Zhou H; Kong L; Zhang J; Zhao Q; Li Y
    Cancer Chemother Pharmacol; 2013 Oct; 72(4):799-808. PubMed ID: 23934262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mammalian Target of Rapamycin (mTOR) Regulates Transforming Growth Factor-β1 (TGF-β1)-Induced Epithelial-Mesenchymal Transition via Decreased Pyruvate Kinase M2 (PKM2) Expression in Cervical Cancer Cells.
    Cheng KY; Hao M
    Med Sci Monit; 2017 Apr; 23():2017-2028. PubMed ID: 28446743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. mTOR inactivation by ROS-JNK-p53 pathway plays an essential role in psedolaric acid B induced autophagy-dependent senescence in murine fibrosarcoma L929 cells.
    Qi M; Zhou H; Fan S; Li Z; Yao G; Tashiro S; Onodera S; Xia M; Ikejima T
    Eur J Pharmacol; 2013 Sep; 715(1-3):76-88. PubMed ID: 23810968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polydatin regulates proliferation, apoptosis and autophagy in multiple myeloma cells through mTOR/p70s6k pathway.
    Yang B; Zhao S
    Onco Targets Ther; 2017; 10():935-944. PubMed ID: 28243129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MTOR inhibition attenuates DNA damage and apoptosis through autophagy-mediated suppression of CREB1.
    Wang Y; Hu Z; Liu Z; Chen R; Peng H; Guo J; Chen X; Zhang H
    Autophagy; 2013 Dec; 9(12):2069-86. PubMed ID: 24189100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autophagy inhibition enhances RAD001-induced cytotoxicity in human bladder cancer cells.
    Lin JF; Lin YC; Yang SC; Tsai TF; Chen HE; Chou KY; Hwang TI
    Drug Des Devel Ther; 2016; 10():1501-13. PubMed ID: 27143856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. microRNA-206 is required for osteoarthritis development through its effect on apoptosis and autophagy of articular chondrocytes via modulating the phosphoinositide 3-kinase/protein kinase B-mTOR pathway by targeting insulin-like growth factor-1.
    Yu Q; Zhao B; He Q; Zhang Y; Peng XB
    J Cell Biochem; 2019 Apr; 120(4):5287-5303. PubMed ID: 30335903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of the PI3K-Akt-mTOR signaling pathway promotes necrotic cell death via suppression of autophagy.
    Wu YT; Tan HL; Huang Q; Ong CN; Shen HM
    Autophagy; 2009 Aug; 5(6):824-34. PubMed ID: 19556857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diverse signaling mechanisms of mTOR complexes: mTORC1 and mTORC2 in forming a formidable relationship.
    Jhanwar-Uniyal M; Wainwright JV; Mohan AL; Tobias ME; Murali R; Gandhi CD; Schmidt MH
    Adv Biol Regul; 2019 May; 72():51-62. PubMed ID: 31010692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autophagy and mTOR signaling during intervertebral disc aging and degeneration.
    Yurube T; Ito M; Kakiuchi Y; Kuroda R; Kakutani K
    JOR Spine; 2020 Mar; 3(1):e1082. PubMed ID: 32211593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.